Sage Journals: Discover world-class research

Open access

Research article

First published 2026

Healthcare resource savings from administering paliperidone palmitate once every 3 months instead of once every month for schizophrenia: a 12-month mirror-image analysis of real-world population-based data

Ke-Fei Wu, Ya-Hui Yang, Chuan-Sheng Hung [...]

Therapeutic Advances in Psychopharmacology

Retricted access

Other

First published 2010-7

A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia

Joris Berwaerts, Adriaan Cleton, Stefaan Rossenu [...]

Journal of Psychopharmacology

Retricted access

Research article

First published 2019-04

Retrospective Analysis of the Effectiveness and Tolerability of Long-Acting Paliperidone Palmitate Antipsychotic in Adolescent First-Episode Schizophrenia Patients

Daniela Petrić, Valentino Rački, Nadija Gačo [...]

Journal of Child and Adolescent Psychopharmacology

Retricted access

Research article

First published 2014-4

Changes in plasma concentrations of risperidone and 9-hydroxyrisperidone and the associated clinical effects during the switch from oral risperidone to extended-release paliperidone tablets in patients with schizophrenia

Dong suk Yang, Sook Jin Seong, Young-Ran Yoon [...]

Journal of Psychopharmacology

Free access

Research article

First published 2018-5

Effectiveness of paliperidone long-acting injection in clinical practice

Paul Nicholas Deslandes, Elan Haf Ward, Kathryn Norris [...]

Therapeutic Advances in Psychopharmacology

Retricted access

Research article

First published 2011-5

A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia

S Gopal, U Vijapurkar, P Lim [...]

Journal of Psychopharmacology

Open access

Research article

First published 2015-8

Treatment response,safety,and tolerability of paliperidone extended release treatment in patients recently diagnosed with schizophrenia

Lars Helldin, Joseph Peuskens, Roland Vauth [...]

Therapeutic Advances in Psychopharmacology

Retricted access

Research article

First published 2015-09

Long-Term Safety of Paliperidone Extended Release in Adolescents with Schizophrenia: An Open-Label,Flexible Dose Study

Adam Savitz, Rosanne Lane, Isaac Nuamah [...]

Journal of Child and Adolescent Psychopharmacology

Open access

Research article

First published 2023

Preliminary data from a 4-year mirror-image and multicentre study of patients initiating paliperidone palmitate 6-monthly long-acting injectable antipsychotic: the Paliperidone 2 per Year study

Juan Antonio García-Carmona, Alba García-Pérez, Guillermo Isidro García [...]

Therapeutic Advances in Psychopharmacology

Retricted access

Research article

First published 2021-9

Discontinuation and relapse with paliperidone palmitate three-monthly for maintenance of schizophrenia: Two year follow-up of use in clinical practice

Phoebe Wallman, Ivana Clark, David Taylor

Journal of Psychopharmacology

Search results